Skip to main
Skip to main
University-wide Navigation

Core Services

The Bio Core commonly engages in assay development/validation/implementation, virtual and wet bench screening, hit identification, and hit/lead candidate validation studies. Virtual and wet bench screening activities in the core employ both commercially available libraries and our exclusive UK-based collections (see Compound Collections). The CTCB Bio Core works closely with the CTCB Chem Core  for medchem-guided probe/lead prioritization. The Bio Core is directed by Professor Steven Van Lanen and co-directed by Professor Chang-Guo Zhan.

 

Ligand-Based Screening

  • Study design/consultation
  • Virtual screen of ≥100K compounds using existing validated ligands as the query

Structure-Based Screening

  • Study design/consultation
  • Virtual screen of ≥100K compounds using an existing protein/enzyme target structure as the query

De novo Drug Design

  • Study design/consultation
  • Design 3-5 diverse ligand scaffolds for an existing protein/enzyme target structure

Chemoinformatics and ADMET Analysis

Representative Publications

Assay Development and Screening

  • Study design/consultation
  • Biochemical/cell-based/whole animal assay development/validation
  • Screens using in-house Compound Collections

Preliminary Formulation

  • Study design/consultation
  • Analytical methods development
  • Computational analysis of physical properties
  • Solubilization with a focus on accepted formulations
  • Stability studies

Toxicology/Metabolism Screening

  • Study design/consultation
  • Hematology, toxicity
  • Microsomal stability

Inquiries

The Bio Core welcomes inquiries from UK investigators with an interest in the application of assay development/validation, virtual or bioactivity-guided screening, and/or chemical biology approaches to facilitate on-going or emerging research projects. For more information and to request services, please contact us.

Contact Us

Funding Acknowledgment Statement

This work was supported by the University of Kentucky COBRE for Translational Chemical Biology (CTCB, NIH P20 GM130456) and the University of Kentucky Center for Clinical and Translational Science (CCTS, NIH UL1 TR001998).